338 related articles for article (PubMed ID: 18383462)
1. A mixture model of nuchal translucency thickness in screening for chromosomal defects.
Wright D; Kagan KO; Molina FS; Gazzoni A; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Apr; 31(4):376-83. PubMed ID: 18383462
[TBL] [Abstract][Full Text] [Related]
2. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan.
Wagner P; Sonek J; Hoopmann M; Abele H; Kagan KO
Ultrasound Obstet Gynecol; 2016 Oct; 48(4):446-451. PubMed ID: 26611869
[TBL] [Abstract][Full Text] [Related]
3. Frontomaxillary facial angle in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks.
Borenstein M; Persico N; Kagan KO; Gazzoni A; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Jul; 32(1):5-11. PubMed ID: 18512854
[TBL] [Abstract][Full Text] [Related]
4. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
Zoppi MA; Ibba RM; Floris M; Monni G
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
[TBL] [Abstract][Full Text] [Related]
5. Screening for trisomies in dichorionic twins by measurement of fetal nuchal translucency thickness according to the mixture model.
Wright D; Syngelaki A; Staboulidou I; Cruz Jde J; Nicolaides KH
Prenat Diagn; 2011 Jan; 31(1):16-21. PubMed ID: 21210476
[TBL] [Abstract][Full Text] [Related]
6. A mixture model of nuchal translucency thickness in screening for chromosomal defects: validation of a single operator dataset.
Gasiorek-Wiens A; Kotsis S; Staboulidou I; Stumm M; Wegner RD; Soergel P; Schippert C; von Kaisenberg CS
Prenat Diagn; 2010 Nov; 30(11):1100-6. PubMed ID: 20925129
[TBL] [Abstract][Full Text] [Related]
7. Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11+0 to 13+6 weeks of gestation.
Kagan KO; Valencia C; Livanos P; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 Jan; 33(1):18-22. PubMed ID: 19031473
[TBL] [Abstract][Full Text] [Related]
8. [Increased nuchal translucency with normal karyotype].
Nicolaides KH; Wegrzyn P
Ginekol Pol; 2005 Aug; 76(8):593-601. PubMed ID: 16363364
[TBL] [Abstract][Full Text] [Related]
9. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
[TBL] [Abstract][Full Text] [Related]
10. Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13 + 6-week scan.
Faiola S; Tsoi E; Huggon IC; Allan LD; Nicolaides KH
Ultrasound Obstet Gynecol; 2005 Jul; 26(1):22-7. PubMed ID: 15937972
[TBL] [Abstract][Full Text] [Related]
11. Comparison of likelihood ratios of first-trimester nuchal translucency measurements: multiples of median, delta or mixture.
Sahota DS; Leung TY; Chen M; Chan LW; Fung TY; Lau TK
Ultrasound Obstet Gynecol; 2010 Jul; 36(1):15-9. PubMed ID: 20503228
[TBL] [Abstract][Full Text] [Related]
12. Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11-14-week scan.
Cicero S; Rembouskos G; Vandecruys H; Hogg M; Nicolaides KH
Ultrasound Obstet Gynecol; 2004 Mar; 23(3):218-23. PubMed ID: 15027007
[TBL] [Abstract][Full Text] [Related]
13. Fetal head-to-trunk volume ratio in chromosomally abnormal fetuses at 11 + 0 to 13 + 6 weeks of gestation.
Falcon O; Cavoretto P; Peralta CF; Csapo B; Nicolaides KH
Ultrasound Obstet Gynecol; 2005 Dec; 26(7):755-60. PubMed ID: 16163740
[TBL] [Abstract][Full Text] [Related]
14. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Baker A; Sahota D; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Jun; 31(6):618-24. PubMed ID: 18461550
[TBL] [Abstract][Full Text] [Related]
15. Absent nasal bone at 11-14 weeks of gestation and chromosomal defects.
Cicero S; Longo D; Rembouskos G; Sacchini C; Nicolaides KH
Ultrasound Obstet Gynecol; 2003 Jul; 22(1):31-5. PubMed ID: 12858299
[TBL] [Abstract][Full Text] [Related]
16. Fetal trunk and head volume in chromosomally abnormal fetuses at 11+0 to 13+6 weeks of gestation.
Falcon O; Peralta CF; Cavoretto P; Auer M; Nicolaides KH
Ultrasound Obstet Gynecol; 2005 Oct; 26(5):517-20. PubMed ID: 16142826
[TBL] [Abstract][Full Text] [Related]
17. Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland.
Gasiorek-Wiens A; Tercanli S; Kozlowski P; Kossakiewicz A; Minderer S; Meyberg H; Kamin G; Germer U; Bielicki M; Hackelöer BJ; Sarlay D; Kuhn P; Klapp J; Bahlmann F; Pruggmayer M; Schneider KT; Seefried W; Fritzer E; von Kaisenberg CS;
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):645-8. PubMed ID: 11844207
[TBL] [Abstract][Full Text] [Related]
18. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
[TBL] [Abstract][Full Text] [Related]
19. Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy.
Brizot ML; Snijders RJ; Butler J; Bersinger NA; Nicolaides KH
Br J Obstet Gynaecol; 1995 Feb; 102(2):127-32. PubMed ID: 7538782
[TBL] [Abstract][Full Text] [Related]
20. First-trimester screening for chromosomal abnormalities by fetal nuchal translucency in a Brazilian population.
Brizot ML; Carvalho MH; Liao AW; Reis NS; Armbruster-Moraes E; Zugaib M
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):652-5. PubMed ID: 11844209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
